Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 6Pain, Postoperative 5Brain Neoplasms 5Lung Neoplasms 3Delirium 3Uterine Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Kidney Neoplasms 2Depression 2Carcinoma, Non-Small-Cell Lung 2Vomiting 1Thromboembolism 1Synovial Cyst 1Surgical Wound Infection 1Supratentorial Neoplasms 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Spondylosis 1Spondylolisthesis 1Spinal Stenosis 1Sleep Initiation and Maintenance Disorders 1Sleep Deprivation 1Scleroderma, Localized 1Radiculopathy 1Prostatic Neoplasms 1Postoperative Hemorrhage 1Pituitary Neoplasms 1Pituitary Diseases 1Otolaryngeal Cancer 1

Interventions

Saline Solution 1Ketamine 1Electroencephalography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Otolaryngeal Cancer × Saline Solution × Clear all
NCT03040024 2021-07-08

Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients

Emory University

Phase 4 Terminated
71 enrolled 17 charts
Head & Neck

Otolaryngeal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡